139 related articles for article (PubMed ID: 5060381)
1. Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol.
Beck RP; Morcos F; Fawcett D; Watanabe M
Am J Obstet Gynecol; 1972 Feb; 112(3):364-8. PubMed ID: 5060381
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
4. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC
Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
7. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
8. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
10. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
Andersen RN; Givens JR; Wiser WL; Umstot ES
Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
[TBL] [Abstract][Full Text] [Related]
11. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
12. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
[TBL] [Abstract][Full Text] [Related]
13. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain.
Ladinsky H; Consolo S; Bianchi S; Peri G; Garattini S
Pharmacology; 1976; 14(3):232-9. PubMed ID: 986656
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the effect of oral contraceptives containing 50 microgram of estrogen and those containing 20 microgram of estrogen on adrenal cortical function.
Amin ES; El-Sayed MM; El-Gamel BA; Nayel SA
Am J Obstet Gynecol; 1980 Aug; 137(7):831-3. PubMed ID: 7405974
[TBL] [Abstract][Full Text] [Related]
16. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V
Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405
[TBL] [Abstract][Full Text] [Related]
17. Study of norethindrone in contraception.
Goldzieher JW; Moses LE; Ellis LT
JAMA; 1962 May; 180(5):359-61. PubMed ID: 12305165
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function studies in different phases of the menstrual cycle and in women receiving norethindrone with and without estrogen.
Beck RP; Fawcett DM; Morcos F
Am J Obstet Gynecol; 1972 Feb; 112(3):369-73. PubMed ID: 4110544
[No Abstract] [Full Text] [Related]
19. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraceptive on liver function tests of women with schistosomiasis in the Philippines.
Sy FS; Osteria TS; Opiniano V; Gler S
Contraception; 1986 Sep; 34(3):283-94. PubMed ID: 3098499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
